pharmaceutical-investing Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union
European Medicines Agency validates Oasmia Pharmaceutical AB’s application to add efficacy data to the approved Apealea
pharmaceutical-investing European CHMP Adopts Positive Opinion for Yescarta (axicabtagene ciloleucel)
pharmaceutical-investing Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab)
Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK